Cyclo Therapeutics at SCOPE 2027

Mar 1–4, 2027 Orlando, FL ~5k attendees Website

Cyclo Therapeutics brings 2 presentations to SCOPE 2027 in Orlando. Its sessions in the SCOPE Biotech Forum cover running trials with lean clinical operations teams. They include oversight and governance with a small team and operating plans for scaling trials globally.

OrganizationSCOPE 2027 Attendance
Biotech
Develops Trappsol Cyclo, a cyclodextrin-based treatment for Niemann-Pick disease type C.
Panel
Tue Mar 2
12:20pm–12:45pm
Trial Oversight and Governance in Lean ClinOps Environments
SCOPE Biotech Forum · with Cognition Therapeutics, Compass Pathways
Quality, monitoring and safetyOutsourcing and budgeting
Talk
Wed Mar 3
2:35pm–3:00pm
Bigger, Faster, Leaner: Operational Blueprints for Global Clinical Scale-Up
SCOPE Biotech Forum
Trial design and deliveryOutsourcing and budgeting

Explore the full SCOPE 2027 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Orlando. Leave your work email and we’ll be in touch.

Privacy

Download the full SCOPE 2027 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Cyclo Therapeutics

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by SCOPE Summit or its organizers. Submit a correction